Healthcare

According to a market report by Lucintel, the future of the western blotting market looks promising with opportunities in academic & research institutes, biopharmaceutical & biotechnology companies, and hospitals & diagnostic laboratories. The global western blotting market is expected to reach an estimated $1.26 billion by 2028 with a CAGR of 5.9% from 2023 to 2028. The major drivers for this market are growing prevalence of HIV/AIDS, increasing preference for precision medicines and rise in research and development activities in biotech and pharma sectors.



In this market, consumables and instruments are the two products of western blotting used by various end use industries. Lucintel forecasts that consumables will remain the larger product segment over the forecast period due to increasing penetration in research and diagnosis activity. 



Within this market, academic & research institutes are expected to remain the largest end use segment due to an increase in investment in the research and development activities by governments. 



North America will remain the largest region due to growing demand from highly developed biotechnology and medical diagnostic sector and increasing funding for research and development activities in the region.

Bio-Rad, Thermo Fisher, Danaher, Bio-Techne, and Merck are the major suppliers in the global western blotting market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global western blotting market by product, application, end use, and region. Lucintel has compiled a comprehensive research report entitled “Growth Opportunities in the Global Western Blotting Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global western blotting market by product, application, end use, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the western blotting market by product (consumables and instrument), application (biomedical and clinical diagnostics), end use (academic & research institutes, biopharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?